Búsqueda avanzada

En la actualidad, Chau Banks ocupa el cargo de Directora de Información y Vicepresidenta Senior en The Clorox Co. En su anterior carrera, la Sra. Banks ocupó el cargo de Directora de Información y Vicepresidenta Ejecutiva de RTW Retailwinds, Inc. y Directora de Tecnología de Revlon, Inc. La Sra. Banks se licenció en la Universidad Estatal de Florida.

On Chau forma parte del consejo de Metropolis Capital Holdings Ltd., Metropolis International Investment Holding Hong Kong Co. Ltd., Metropolis Lnternational Leasing Co. Ltd. y Xin You Cangzhou Real Estate Development Co. Ltd. Se licenció en la Universidad Normal de Shanghai.

Chau Young Lin currently works at International Integrated Systems, Inc. (New), as Chairman from 2020, Chunghwa Precision Test Tech Co., Ltd., as Director from 2020, and Chunghwa Telecom Co., Ltd., as President from 2023.
Dr. Lin received his doctorate degree from National Taiwan University of Science & Technology.

Lee C. Banks es presidente, director de operaciones y director de Parker-Hannifin Corp. El Sr. Banks también forma parte del consejo de Westinghouse Air Brake Technologies Corp., MAPI, Inc. y Wabtec Corp. En su anterior carrera profesional ocupó el cargo de Presidente del Grupo Hidráulico. Se licenció en la Universidad DePauw y obtuvo un MBA en la Keller Graduate School of Management.

Samuel Dean Banks fundó Connective Orthopaedics, Inc., Stratifund, Inc. y Vergent Bioscience, Inc. El Sr. Banks es Presidente, Consejero Delegado y Director de Tyson Foods, Inc. En su trayectoria profesional anterior fue presidente de Stratifund, Inc., director general y consejero de Connective Orthopaedics, Inc., director general y consejero de Vergent Bioscience, Inc., vicepresidente de Highland Capital Partners LLC y vicepresidente senior de desarrollo empresarial y marketing estratégico de OrthoHelix Surgical Designs, Inc. Se licenció en la Universidad de Miami y obtuvo un MBA en la Harvard Business School.

David Banks ocupa el cargo de Director de Operaciones de Santos Ltd. En su anterior carrera, el Sr. Banks ocupó el cargo de Director en BHP Group Ltd.

David C.
P.
Banks formerly worked at Tabcorp Holdings Ltd., as Chief Executive Officer-Casinos Division, The Star Entertainment Sydney Holdings Ltd., as Chief Executive Officer, Aristocrat Leisure Ltd., as Independent Non-Executive Director from 2012 to 2018, Australasian Gaming Council, as Director, Galaxy Entertainment Group Ltd., as Group Chief Operating Officer, and Australian Casinos Association, as President.

Jennifer J.
Banks is currently the Director-Los Angeles Real Estate & Construction at City of Hope National Cancer Institute and a Member at the American Bar Association.
Previously, she worked at Alexandria Real Estate Equities, Inc. as the Co-COO, Secretary & General Counsel from 2018 to 2020.
Ms. Banks completed her undergraduate studies at the University of California, Los Angeles and obtained her graduate degree from Stanford Law School.

Actualmente, Adam Banks es Director de Tecnología e Información en A.P. Mller-Mrsk A.

Gloria C. Banks ocupa el cargo de Vicepresidenta Ejecutiva y Directora de Ética de Synovus Financial Corp. y Directora de Cumplimiento de Synovus Bank (Columbus, Georgia) (una filial de Synovus Financial Corp.). También forma parte del consejo de la National Foundation For Credit Counseling, Inc. Anteriormente, la Sra. Banks ocupó el cargo de Vicepresidenta y Directora de Cumplimiento de Riesgos Corporativos Nacionales en Comerica Bank & Trust, NA. Gloria C. Banks se licenció en la Universidad Central de Michigan y se graduó en el Detroit College of Business.

Mr. Paul Chau is a Senior Partner in the San Francisco office.
He brings over 20 years of venture capital, private equity, consulting and technical expertise and currently focuses on tech investments as well as management of WI Harper’s information technology and medical technology companies in the U.S.
Mr. Chau presently serves on the Board of Roadzen and Dynosense.
He has previously been a Board Director for DivX (NASDAQ IPO), USI Insurance Corporation (NASDAQ IPO, later acquired by Goldman Sachs), Maxic Technology, Ultriva (acquired by Upland Software) and LogicEase (acquired by CoreLogic).
His investment history also includes Fortinet (NASDAQ: FTNT), Equant (NYSE IPO), Tularik (NASDAQ IPO), Ooma (NASDAQ IPO), Solar Power Inc (NASDAQ:SOPW), Airy3D, Alpha Ring, Avaamo, Cnano Technology, Embark Trucks, Maxthon.
Ultracision (acquired by Johnson & Johnson), Windyvale and Verisilicon.
Mr. Chau has been with WI Harper since 2001.
Previously, Mr. Chau was at Walden International, handling investment sourcing and execution as well as portfolio management.
He was also formerly at GIC (Government of Singapore Investment Corporation), where he directed private equity and venture capital investments in the U.S.
Before joining GIC, Mr. Chau was a Senior Consultant with BARRA, a financial consulting company for pension funds and money management firms.
Mr. Chau holds an MBA from UC Berkeley and a BS in Electrical Engineering from University of Canterbury.

Chau Nguyen formerly worked at Saigon Thuong Tin Commercial Joint Stock Bank, as Vice Chairman & Secretary from 2010 to 2011.
Mr. Nguyen received his graduate degree from Ho Chi Minh City University of Law.

Joe Chau is Head of CMC & Formulation Development for Cortria Corp.
Prior to joining Cortria, he was Director of Chemistry Manufacturing and Controls for Cardiome Pharma Corp.
from 2002 to 2005.
Previously, he was Senior Manager of API Process Sciences at QLT, Inc. and Senior Research Chemist at EACOM Timber Corp.
Dr. Chau received a BSc degree in Organic Chemistry from the University of Manitoba, a PhD in Synthethic Organic Chemistry from the University of Calgary and a Post-Doctoral Research Fellowship in Combinatorial Chemistry from Duke University.

Mr. Keith Chau is a Senior Analyst at MST Financial Services Pty Ltd.
He has thirteen years of experience in equity research covering building materials, chemicals, packaging and steel sectors.
Mr. Chau joined MST in July 2019.
He previously worked at Evans & Partners, and prior to that he was an Executive Director at J.P.
Morgan in the equities research team.
Mr. Chau spent three years at PricewaterhouseCoopers in the corporate finance and valuation & strategy team.
Mr. Chau graduated from the University of Otago in New Zealand with a Bachelor of Commerce and Bachelor of Science Major in Pharmacology.

Wilson Chau is currently a member of The Association of International Accountants and the Hong Kong Institute of Certified Public Accountants.
He previously worked as a Finance Manager at Uni Core Holdings Corp.
from 2007 to 2012.

Ching Chau is the founder of Sharp Success Enterprises Ltd.
(founded in 1995), MS Group Holdings Ltd.
(founded in 2007), and Main Success Industrial Ltd.
(founded in 2007).
Mr. Chau holds the title of Chairman at MS Group Holdings Ltd.
and Director at Main Success Industrial Ltd.

Formerly the Founding Director and Chief Financial Officer of a boutique asset management company with the SFC Type 9 license and AUM of US$1 billion.
From 2003 to 2008, Ms Chau served as Head of Regulatory Reporting for Standard Chartered Bank (Hong Kong) Limited.
Ms Chau managed the compliance reporting team and supervised the bank’s major financial risks with the Finance Department, Treasury department and Legal and Compliance department to ensure that the bank complies with the requirements of the Hong Kong Monetary Authority (HKMA).
Ms Chau was the main point of contact between the bank and regulators (including the HKMA and the Census and Statistics Department) Before Standard Chartered Bank, Ms Chau joined Arthur Andersen Hong Kong in 1995.
In 2002, Ms Chau joined PricewaterhouseCoopers, providing consulting services on auditing, finance, risk management, performance improvement advisory, and M&A, IPO transactions for various financial institutions and corporates spread across Greater China.
Ms Chau has extensive experience in planning IPOs and was one of the key members of the Bank of China restructuring and H+A share listing projects.
Ms Chau earned the Hong Kong Institute of Certified Public Accountants (HKICPA) designation in 1998 and the Association of Chartered Certified Accountants (ACCA) designation in 1999

Ms. Tristen Chau was previously employed as an Analyst by Stifel, Nicolaus & Co., Inc.

Jorge L.
Chau is currently the Director of the Scientific Committee on Solar-Terrestrial Physics (SCOSTEP).

Edward Chau joined TorQuest in January 2013 and has more than ten years of experience in financial and tax reporting for private equity funds.
Prior to joining TorQuest, Edward was the Controller at EdgeStone Capital Partners.
Edward is a Certified General Accountant and a member of the institute of Chartered Accountants in England and Wales.

Bernard W.
Chau is a Member of the American Institute of Aeronautics & Astronautics.
He was a Vice President-National Intelligence Operations at The Aerospace Corp.
from 1992 to 2015.
He has a graduate degree from the University of Southern California, an undergraduate degree from the University of Hawai'i at Hilo, and an undergraduate degree from the Defense Systems Management College.

Chit Chau formerly worked at UMP Healthcare Holdings Ltd., as Independent Non-Executive Director from 2021 to 2023.
Mr. Chau received his graduate degree from Stanford University and undergraduate degree from The Hong Kong University of Science & Technology.

Jack Chau worked as a Managing Director at Värde Partners.
Prior to that, he completed his undergraduate degree at Rutgers University, Camden.

Jany Chau is the founder of Crayon Digital Pte.
Ltd.
Prior to founding Crayon Digital, she worked as a Commissioner at PT Northcliff Citranusa Indonesia Tbk.
She received her undergraduate degree from Macquarie University in 1994.

Chau Thai has worked as a Director at Can Tho Mineral & Cement JSC since 2012.

David Chau is currently the Chairman & Chief Executive Officer at Metropolis Capital Holdings Ltd.
He also holds director positions at Metropolis International Investment Holding Hong Kong Co. Ltd., Metropolis International Leasing Co. Ltd., View Art Investment Ltd., and Metropolis Asia Ltd.
Previously, he was a Director at Xinren Finance Leasing Shanhai Co. Ltd.
Mr. Chau received his undergraduate degree from the University of British Columbia in 2007.

Tuan Chau is associated with Cat Loi JSC, Hoaviet JSC, and Saigon Tobacco Co., Ltd.

Celia Chau worked as a Portfolio Manager at BlackRock Asset Management North Asia Ltd.
from 2007 to 2019.

Dr. Doug Chau is a Chief Risk Officer & Head of Research at University of Toronto Asset Management Corp.
He joined the firm in 2017 and is responsible for asset allocation modeling, risk management and measurement, research, and performance analysis.
Doug chairs the Management Investment Risk Committee and is a member of several other internal management committees.
Previously, Dr. Chau worked for 15 years at OPTrust, where his responsibilities included developing strategic allocation models, risk factor research, internal and external portfolio evaluations, implementing performance and ALM systems and developing a set of quantitative tools to inform investment decisions.
He holds a PhD in Finance from the EDHEC Business School, a Master’s degree in Science with a specialization in Finance from the University of Reading, a Master’s degree in Statistics from the University of Toronto, and a Bachelor’s degree in Mathematics and its Applications from the University of Toronto.
In addition, he holds the Chartered Financial Analyst, Professional Risk Manager and Certificate in Quantitative Finance designations.

Mr. Tanguy Chau is a Principal at Formation8 Partners LLC.
Prior to Formation 8, Mr. Chau managed teams and projects for McKinsey & Company's tech and healthcare practice in Palo Alto.
Before that, he led energy investments with the Angeleno Group, a growth equity firm in Los Angeles.
He also founded Sample6 Technologies (formerly Novophage), a synthetic biology company enhancing food safety.
He served on the Board of Directors for the Harvard COOP and was elected to the MIT Board of Trustees in 2012.
Mr. Chau received his PhD in Chemical Engineering and MBA in Finance from MIT and was a University Medal Finalist at UC Berkeley where he completed his undergraduate.

Tinnie Chau is currently working as a Vice President at Ally Bridge Group HK Ltd since 2015.
She completed her undergraduate degree from the University of Cambridge in 2009.

Bonnie Chau is a Portfolio Manager at BCF Ventures with diversified expertise in the areas of entrepreneurship, finance, accounting and investment.
Bonnie currently leads the due diligence for B2B startups and provides support to the portfolio companies.
Prior to becoming a VC at BCF Ventures, she has honed her operating skills at one of the fastest growing fintech companies in Canada by providing her expertise in Finance/Accounting, and she was later promoted to execute on interim management projects working directly with the CEO and CFO.
The culmination of Bonnie’s interpersonal, management and investment expertise has proven invaluable to the team, earning her a recognition to the GCV Top 50 Rising Star Award in 2022.
She always looks for opportunities to give back to the startup community; Bonnie is an angel investor, an advisor on multiple startups, and a mentor at accelerator programs.
Bonnie holds a Bachelor of Commerce with an Accounting major from the Desautels Faculty of Management at McGill University, and she has earned her CPA accounting designation.

Alexandre Chau has worked as the Chief Executive Officer and Director at Endo Tools Therapeutics SA since 2011.

Laura Chau is currently the Director at Mosey Works, Inc. She is also a Partner at Canaan Management, Inc., a Board Member at Clutch Technologies, Inc., and a Board Member at Nate, Inc. In the past, she held positions as a Director at Cargomatic, Inc., Coterie, Inc., ClusterHQ Ltd., Cuyana, Inc., and Beckon, Inc. She was also a Principal at Deloitte Consulting Ventures and a Market Intern at Kabam, Inc. Additionally, Ms. Chau served as a Board Member at Ollie Pets, Inc. and Confetti Collective, Inc. She completed her undergraduate degree at Stanford University and holds an MBA from Stanford Graduate School of Business.

Wai Hung Chau currently works at Novel Enterprises Ltd., as Secretary.

Randy Chau is the founder of Panzura LLC, Pixel8 Networks, Inc., Nubeva, Inc., and Nubeva Technologies Ltd.
Panzura LLC was founded in 2008, Pixel8 Networks, Inc. was founded in 2008, Nubeva, Inc. was founded in 2016, and Nubeva Technologies Ltd.
was founded in 2017.
Mr. Chau held the title of Chief Executive Officer & Director at Panzura LLC from 2013 to 2016, Chief Executive Officer at Pixel8 Networks, Inc. in 2010, and President, Chief Executive Officer & Director at Nubeva, Inc. and Nubeva Technologies Ltd.
Mr. Chau's former jobs include Principal positions at Alteon WebSystems, Inc. and Aruba Networks, Inc. Mr. Chau received an undergraduate degree from the University of California, Berkeley.

Annie Chau is a Chief Operating & Compliance Officer at Angeles Equity Partners LLC since 2014.
She previously held positions as a Board Member at United Road Services, Inc., Sage Automotive Interiors, Inc., and Cosmo Specialty Fibers, Inc. She was also a Principal at Merrill Lynch Global Private Equity, Inc. and a Vice President at The Gores Group LLC.
Ms. Chau received her undergraduate and graduate degrees from Stanford University.

Chau Wai-Yan was the founder of Achievo Corp.
(founded in 2002) and Universal Semiconductor, Inc. (founded in 1978), where they held the titles of Director and Chief Executive Officer respectively.
Mr. Wai-Yan's current job(s) include being a Director at Eureka Therapeutics, Inc. and President at TridentUSA Health Services LLC (since 1999).
Mr. Wai-Yan's former job(s) include being Chairman at CITIC Shenzhen (Group) Co. Ltd.
(1997), Director at Crown Bioscience, Inc., Director at Accela, Inc., and President at Pacific Construction Co., Ltd.
(1992-1995).
Mr. Wai-Yan obtained an undergraduate degree and an MBA from the University of California, Berkeley.

Ms. Chau joined FFL in 2005.
Previously, she was at United Commercial Bank (“UCBH”) as First Vice President and Project Manager for enterprise-wide compliance with the Sarbanes-Oxley Act.
Prior to UCBH, Alice worked as Assistant Controller at H&Q Asia Pacific, an international private equity firm with over $1 billion of capital under management.
Her responsibilities included all of the operational and financial aspects of the firm’s funds.
Previously, she was a Senior Associate at PricewaterhouseCoopers LLP where she served clients in the financial services sector.
Ms. Chau graduated with honors from California Polytechnic State University, San Luis Obispo.

Chau Quang Khuong is currently a Director at Cerapedics, Inc., Rempex Pharmaceuticals, Inc., Galecto Biotech ApS, Synlogic Operating Co., Inc., NextCure, Inc., ReViral Ltd., Perfuse Therapeutics, Inc., Galecto, Inc., OnCusp Therapeutics, Inc., and Nabriva Therapeutics GmbH.
Mr. Khuong has formerly held positions as Chairman at Marika, Inc., Chairman at Pieris Pharmaceuticals, Inc., Director at BELLUS Health, Inc., Director at Arius Research, Inc., Director at Intercept Pharmaceuticals, Inc., Director at Glaukos Corp., Director at Sonendo, Inc., Director at Graybug Vision, Inc., Director at Aerpio Therapeutics, Inc., Director at Pieris AG, Director at NeurAxon, Inc., Independent Director at Inspire Medical Systems, Inc., Director at Arius, Inc., Independent Director at Otonomy, Inc., Director at Durata Therapeutics, Inc., Director at Intellia Therapeutics, Inc., Independent Director at Fusion Pharmaceuticals, Inc., Independent Director at Aerpio Pharmaceuticals, Inc., Independent Director at Nabriva Therapeutics Plc, Independent Director at Synlogic, Inc., Director at Gennao Bio, Inc., Partner at OrbiMed Advisors LLC, Principal at The General Hospital Corp., Manager at Veritas Medicine, Inc., Principal at OrbiMed Advisors Private Equity, Principal at Yale School of Medicine, and General Partner & Senior Advisor at Catalio Capital Management LP.
Mr. Khuong's education includes undergraduate and graduate degrees from Yale University.

Ling Chau served as the Chief Executive Officer & Executive Director at Prosperous Future Holdings Ltd.
from 2018 to 2019.
Mr. Chau obtained an undergraduate degree from The Chinese University of Hong Kong in 2006.